Osteopontin Expression and Serum Levels in Metastatic Uveal Melanoma: A Pilot Study-Reference-Cited by-同舟云学术

Osteopontin Expression and Serum Levels in Metastatic Uveal Melanoma: A Pilot Study

Published:2006-03-01 Issue:3 Volume:47 Page:802
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Kadkol ShriHari S.¹,Lin Amy Y.²,Barak Vivian³,Kalickman Inna³,Leach Lu²,Valyi-Nagy Klara²,Majumdar Dibyen⁴,Setty Suman²,Maniotis Andrew J.¹,Folberg Robert¹,Pe’er Jacob⁵

Affiliation:

1. From the Department of Pathology, the2Cancer Center, and the

2. From the Department of Pathology, the

3. Immunology Laboratory for Tumor Diagnosis and the

4. Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, Illinois; and the

5. Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP;Acta Pharmaceutica Sinica B;2024-09

2. Osteopontin in cancer;Advances in Clinical Chemistry;2024

3. Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis;Canadian Journal of Ophthalmology;2024-01

4. A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival;BMC Cancer;2023-03-27

5. Metastatic uveal melanoma: The final frontier;Progress in Retinal and Eye Research;2022-09